JP2009519462A - 改良型のサンプル受けデバイスを備えるイオン移動度分光分析器 - Google Patents
改良型のサンプル受けデバイスを備えるイオン移動度分光分析器 Download PDFInfo
- Publication number
- JP2009519462A JP2009519462A JP2008545147A JP2008545147A JP2009519462A JP 2009519462 A JP2009519462 A JP 2009519462A JP 2008545147 A JP2008545147 A JP 2008545147A JP 2008545147 A JP2008545147 A JP 2008545147A JP 2009519462 A JP2009519462 A JP 2009519462A
- Authority
- JP
- Japan
- Prior art keywords
- sample
- ion mobility
- receiving device
- spectrometry system
- sample receiving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 claims abstract description 65
- 238000005070 sampling Methods 0.000 claims description 118
- 238000001871 ion mobility spectroscopy Methods 0.000 claims description 88
- 150000002500 ions Chemical class 0.000 claims description 71
- 239000000758 substrate Substances 0.000 claims description 54
- 238000001514 detection method Methods 0.000 claims description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims description 39
- 239000000126 substance Substances 0.000 claims description 28
- 230000007246 mechanism Effects 0.000 claims description 21
- 238000003795 desorption Methods 0.000 claims description 19
- 239000012491 analyte Substances 0.000 claims description 15
- 238000003780 insertion Methods 0.000 claims description 15
- 230000037431 insertion Effects 0.000 claims description 15
- 239000007789 gas Substances 0.000 claims description 13
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical group NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 10
- 238000000451 chemical ionisation Methods 0.000 claims description 9
- 239000000376 reactant Substances 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 230000005684 electric field Effects 0.000 claims description 6
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 229940047889 isobutyramide Drugs 0.000 claims description 3
- 230000001877 deodorizing effect Effects 0.000 claims description 2
- 238000004817 gas chromatography Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 150000001805 chlorine compounds Chemical group 0.000 claims 2
- 229910052695 Americium Inorganic materials 0.000 claims 1
- LXQXZNRPTYVCNG-UHFFFAOYSA-N americium atom Chemical compound [Am] LXQXZNRPTYVCNG-UHFFFAOYSA-N 0.000 claims 1
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 234
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 20
- 239000000463 material Substances 0.000 description 19
- 239000002360 explosive Substances 0.000 description 14
- -1 ammonium ions Chemical class 0.000 description 11
- 229960003920 cocaine Drugs 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 229960000620 ranitidine Drugs 0.000 description 10
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 10
- 239000004081 narcotic agent Substances 0.000 description 9
- 238000004887 air purification Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 229910002651 NO3 Inorganic materials 0.000 description 5
- 239000000356 contaminant Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 229910052907 leucite Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 description 3
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 3
- AGUIVNYEYSCPNI-UHFFFAOYSA-N N-methyl-N-picrylnitramine Chemical compound [O-][N+](=O)N(C)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O AGUIVNYEYSCPNI-UHFFFAOYSA-N 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 3
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- UQXKXGWGFRWILX-UHFFFAOYSA-N ethylene glycol dinitrate Chemical compound O=N(=O)OCCON(=O)=O UQXKXGWGFRWILX-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229950002454 lysergide Drugs 0.000 description 3
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 3
- 229960004961 mechlorethamine Drugs 0.000 description 3
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- SPSSULHKWOKEEL-UHFFFAOYSA-N 2,4,6-trinitrotoluene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O SPSSULHKWOKEEL-UHFFFAOYSA-N 0.000 description 2
- BUCORZSTKDOEKQ-UHFFFAOYSA-N 7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine Chemical compound C=12C=C(Cl)C=CC2=NC(=NC)CN(O)C=1C1=CC=CC=C1 BUCORZSTKDOEKQ-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 239000000006 Nitroglycerin Substances 0.000 description 2
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- DYAHQFWOVKZOOW-UHFFFAOYSA-N Sarin Chemical compound CC(C)OP(C)(F)=O DYAHQFWOVKZOOW-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002730 additional effect Effects 0.000 description 2
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
- 229960004538 alprazolam Drugs 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 2
- 229960003291 chlorphenamine Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960002069 diamorphine Drugs 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- QIQNNBXHAYSQRY-UHFFFAOYSA-N ecgonine methyl ester Natural products C1C(O)C(C(=O)OC)C2CCC1N2C QIQNNBXHAYSQRY-UHFFFAOYSA-N 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 240000004308 marijuana Species 0.000 description 2
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229960001252 methamphetamine Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 230000003533 narcotic effect Effects 0.000 description 2
- UZGLIIJVICEWHF-UHFFFAOYSA-N octogen Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)CN([N+]([O-])=O)C1 UZGLIIJVICEWHF-UHFFFAOYSA-N 0.000 description 2
- 229960002085 oxycodone Drugs 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 229950010883 phencyclidine Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- PVXVWWANJIWJOO-VIFPVBQESA-N (2s)-1-(1,3-benzodioxol-5-yl)-n-ethylpropan-2-amine Chemical compound CCN[C@@H](C)CC1=CC=C2OCOC2=C1 PVXVWWANJIWJOO-VIFPVBQESA-N 0.000 description 1
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- AMGNHZVUZWILSB-UHFFFAOYSA-N 1,2-bis(2-chloroethylsulfanyl)ethane Chemical compound ClCCSCCSCCCl AMGNHZVUZWILSB-UHFFFAOYSA-N 0.000 description 1
- YSIBQULRFXITSW-OWOJBTEDSA-N 1,3,5-trinitro-2-[(e)-2-(2,4,6-trinitrophenyl)ethenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1\C=C\C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O YSIBQULRFXITSW-OWOJBTEDSA-N 0.000 description 1
- USWVWJSAJAEEHQ-UHFFFAOYSA-N 1,3-benzodioxolyl-n-methylbutanamine Chemical compound CCC(NC)CC1=CC=C2OCOC2=C1 USWVWJSAJAEEHQ-UHFFFAOYSA-N 0.000 description 1
- PVXVWWANJIWJOO-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine Chemical compound CCNC(C)CC1=CC=C2OCOC2=C1 PVXVWWANJIWJOO-UHFFFAOYSA-N 0.000 description 1
- CFJMRBQWBDQYMK-UHFFFAOYSA-N 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester Chemical compound C=1C=CC=CC=1C1(C(=O)OCCOCCN(CC)CC)CCCC1 CFJMRBQWBDQYMK-UHFFFAOYSA-N 0.000 description 1
- YOVRGSHRZRJTLZ-HZPDHXFCSA-N 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol Chemical compound C1=C(C(O)=O)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 YOVRGSHRZRJTLZ-HZPDHXFCSA-N 0.000 description 1
- RMBFBMJGBANMMK-UHFFFAOYSA-N 2,4-dinitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O RMBFBMJGBANMMK-UHFFFAOYSA-N 0.000 description 1
- QXRUNSUMQBTCQS-UHFFFAOYSA-N 2-[ethoxy(ethyl)phosphoryl]sulfanyl-n,n-diethylethanamine Chemical compound CCOP(=O)(CC)SCCN(CC)CC QXRUNSUMQBTCQS-UHFFFAOYSA-N 0.000 description 1
- BKWMHKJLXIRTAI-UHFFFAOYSA-N 2-[ethoxy(methyl)phosphoryl]sulfanyl-n,n-diethylethanamine Chemical compound CCOP(C)(=O)SCCN(CC)CC BKWMHKJLXIRTAI-UHFFFAOYSA-N 0.000 description 1
- IEEJAAUSLQCGJH-UHFFFAOYSA-N 2-amino-4,6-dinitrotoluene Chemical compound CC1=C(N)C=C([N+]([O-])=O)C=C1[N+]([O-])=O IEEJAAUSLQCGJH-UHFFFAOYSA-N 0.000 description 1
- PJISLFCKHOHLLP-UHFFFAOYSA-N 2-diethoxyphosphorylsulfanyl-n,n-diethylethanamine Chemical compound CCOP(=O)(OCC)SCCN(CC)CC PJISLFCKHOHLLP-UHFFFAOYSA-N 0.000 description 1
- FVGMOUUULYIIEE-UHFFFAOYSA-N 2-methyl-1,3-dinitropentane Chemical compound CCC([N+]([O-])=O)C(C)C[N+]([O-])=O FVGMOUUULYIIEE-UHFFFAOYSA-N 0.000 description 1
- LPLLVINFLBSFRP-UHFFFAOYSA-N 2-methylamino-1-phenylpropan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC=C1 LPLLVINFLBSFRP-UHFFFAOYSA-N 0.000 description 1
- ZTLXICJMNFREPA-UHFFFAOYSA-N 3,3,6,6,9,9-hexamethyl-1,2,4,5,7,8-hexaoxonane Chemical compound CC1(C)OOC(C)(C)OOC(C)(C)OO1 ZTLXICJMNFREPA-UHFFFAOYSA-N 0.000 description 1
- NGBBVGZWCFBOGO-UHFFFAOYSA-N 3,4-Methylenedioxyamphetamine Chemical compound CC(N)CC1=CC=C2OCOC2=C1 NGBBVGZWCFBOGO-UHFFFAOYSA-N 0.000 description 1
- KQRJATLINVYHEZ-UHFFFAOYSA-N 4-amino-2,6-dinitrotoluene Chemical compound CC1=C([N+]([O-])=O)C=C(N)C=C1[N+]([O-])=O KQRJATLINVYHEZ-UHFFFAOYSA-N 0.000 description 1
- ZPTVNYMJQHSSEA-UHFFFAOYSA-N 4-nitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C=C1 ZPTVNYMJQHSSEA-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- JJGYGPZNTOPXGV-SSTWWWIQSA-N 6-Acetylmorphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O JJGYGPZNTOPXGV-SSTWWWIQSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 1
- KZFBHCCLJSAHBQ-UHFFFAOYSA-N Benzoylecgonine Natural products CN1C2CCC1C(C(C2)OC(=C)c3ccccc3)C(=O)O KZFBHCCLJSAHBQ-UHFFFAOYSA-N 0.000 description 1
- 108030001720 Bontoxilysin Proteins 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- VMIYHDSEFNYJSL-UHFFFAOYSA-N Bromazepam Chemical compound C12=CC(Br)=CC=C2NC(=O)CN=C1C1=CC=CC=N1 VMIYHDSEFNYJSL-UHFFFAOYSA-N 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- NMPOSNRHZIWLLL-XUWVNRHRSA-N Cocaethylene Chemical group O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OCC)C(=O)C1=CC=CC=C1 NMPOSNRHZIWLLL-XUWVNRHRSA-N 0.000 description 1
- PHMBVCPLDPDESM-YWIQKCBGSA-N Ecgonine Natural products C1[C@H](O)[C@@H](C(O)=O)[C@H]2CC[C@@H]1N2C PHMBVCPLDPDESM-YWIQKCBGSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- ZAGRKAFMISFKIO-UHFFFAOYSA-N Isolysergic acid Natural products C1=CC(C2=CC(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- QMMZSJPSPRTHGB-UHFFFAOYSA-N MDEA Natural products CC(C)CCCCC=CCC=CC(O)=O QMMZSJPSPRTHGB-UHFFFAOYSA-N 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- GRXKLBBBQUKJJZ-UHFFFAOYSA-N Soman Chemical compound CC(C)(C)C(C)OP(C)(F)=O GRXKLBBBQUKJJZ-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 1
- LJWZOKOFCBPNAG-UHFFFAOYSA-N Trichothecin Natural products CC=CC(=O)OC1CC2OC3C=C(C)C(=O)CC3(C)C1(C)C21CO1 LJWZOKOFCBPNAG-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- UATJOMSPNYCXIX-UHFFFAOYSA-N Trinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 UATJOMSPNYCXIX-UHFFFAOYSA-N 0.000 description 1
- JJIUCEJQJXNMHV-UHFFFAOYSA-N VX nerve agent Chemical compound CCOP(C)(=O)SCCN(C(C)C)C(C)C JJIUCEJQJXNMHV-UHFFFAOYSA-N 0.000 description 1
- PJVJTCIRVMBVIA-JTQLQIEISA-N [dimethylamino(ethoxy)phosphoryl]formonitrile Chemical compound CCO[P@@](=O)(C#N)N(C)C PJVJTCIRVMBVIA-JTQLQIEISA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- PBNSPNYJYOYWTA-UHFFFAOYSA-N adamsite Chemical compound C1=CC=C2[As](Cl)C3=CC=CC=C3NC2=C1 PBNSPNYJYOYWTA-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- LXQXZNRPTYVCNG-YPZZEJLDSA-N americium-241 Chemical compound [241Am] LXQXZNRPTYVCNG-YPZZEJLDSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229960000794 baclofen Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940053031 botulinum toxin Drugs 0.000 description 1
- 229960002729 bromazepam Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229950002698 cathinone Drugs 0.000 description 1
- PUAQLLVFLMYYJJ-ZETCQYMHSA-N cathinone Chemical compound C[C@H](N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-ZETCQYMHSA-N 0.000 description 1
- 229960004782 chlordiazepoxide Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- MLDPKSMXFMVXEW-UHFFFAOYSA-N chlorosylformyl chloride Chemical compound C(=O)(Cl=O)Cl MLDPKSMXFMVXEW-UHFFFAOYSA-N 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- DQRLCTAGMVGVFH-UHFFFAOYSA-N cyanide;hydrochloride Chemical compound Cl.N#[C-] DQRLCTAGMVGVFH-UHFFFAOYSA-N 0.000 description 1
- SNTRKUOVAPUGAY-UHFFFAOYSA-N cyclosarin Chemical compound CP(F)(=O)OC1CCCCC1 SNTRKUOVAPUGAY-UHFFFAOYSA-N 0.000 description 1
- PHMBVCPLDPDESM-UHFFFAOYSA-N d-Pseudoekgonin Natural products C1C(O)C(C(O)=O)C2CCC1N2C PHMBVCPLDPDESM-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- LQSFEOMOHFPNEB-UHFFFAOYSA-N dichloro(ethyl)arsane Chemical compound CC[As](Cl)Cl LQSFEOMOHFPNEB-UHFFFAOYSA-N 0.000 description 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- DWCLXOREGBLXTD-UHFFFAOYSA-N dmdnb Chemical compound [O-][N+](=O)C(C)(C)C(C)(C)[N+]([O-])=O DWCLXOREGBLXTD-UHFFFAOYSA-N 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- PHMBVCPLDPDESM-FKSUSPILSA-N ecgonine Chemical compound C1[C@H](O)[C@H](C(O)=O)[C@H]2CC[C@@H]1N2C PHMBVCPLDPDESM-FKSUSPILSA-N 0.000 description 1
- GVGYEFKIHJTNQZ-RFQIPJPRSA-N ecgonine benzoate Chemical compound O([C@@H]1[C@@H]([C@H]2CC[C@@H](C1)N2C)C(O)=O)C(=O)C1=CC=CC=C1 GVGYEFKIHJTNQZ-RFQIPJPRSA-N 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002200 flunitrazepam Drugs 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-N fluorophosphoric acid Chemical compound OP(O)(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- VHHHONWQHHHLTI-UHFFFAOYSA-N hexachloroethane Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)Cl VHHHONWQHHHLTI-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 235000021190 leftovers Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- ZAGRKAFMISFKIO-QMTHXVAHSA-N lysergic acid Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-QMTHXVAHSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- VXRMBBLRHSRVDK-UHFFFAOYSA-N methyldichloroarsine Chemical compound C[As](Cl)Cl VXRMBBLRHSRVDK-UHFFFAOYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960003436 pentoxyverine Drugs 0.000 description 1
- DAFIBNSJXIGBQB-UHFFFAOYSA-N perfluoroisobutene Chemical compound FC(F)=C(C(F)(F)F)C(F)(F)F DAFIBNSJXIGBQB-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- UDHDFEGCOJAVRE-UHFFFAOYSA-N phenyldichloroarsine Chemical compound Cl[As](Cl)C1=CC=CC=C1 UDHDFEGCOJAVRE-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- RPQXVSUAYFXFJA-HGRQIUPRSA-N saxitoxin Chemical compound NC(=O)OC[C@@H]1N=C(N)N2CCC(O)(O)[C@@]22N=C(N)N[C@@H]12 RPQXVSUAYFXFJA-HGRQIUPRSA-N 0.000 description 1
- RPQXVSUAYFXFJA-UHFFFAOYSA-N saxitoxin hydrate Natural products NC(=O)OCC1N=C(N)N2CCC(O)(O)C22NC(N)=NC12 RPQXVSUAYFXFJA-UHFFFAOYSA-N 0.000 description 1
- 229960002060 secobarbital Drugs 0.000 description 1
- KQPKPCNLIDLUMF-UHFFFAOYSA-N secobarbital Chemical compound CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O KQPKPCNLIDLUMF-UHFFFAOYSA-N 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- LJWZOKOFCBPNAG-HULHSAFCSA-N trichothecin Chemical compound C([C@@]12[C@@]3(C)[C@@]4(C)CC(=O)C(C)=C[C@H]4O[C@@H]1C[C@H]3OC(=O)\C=C/C)O2 LJWZOKOFCBPNAG-HULHSAFCSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
- G01N27/622—Ion mobility spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/16—Injection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Electrochemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Sampling And Sample Adjustment (AREA)
- Electron Tubes For Measurement (AREA)
Abstract
Description
この実施例は、単一のモード、たとえば、正のモードなどでは区別することができない物質が、両方の極性モードで解析されたとき、いかにして互いに区別されることができるかを示している。たとえば、ラニチジンおよびコカインは、正のモードでは、類似の移動度定数を有する。しかし、ラニチジンのみが、負のイオンモードでイオン化される。図18〜20は、表2に示すパラメータで実行された、Ionscan(登録商標)500DTイオン移動度分光計(Smith Detection,Inc.)を使用して得られた検知ピークパターンを示している。図18は、図示のように、正のモードでのラニチジンに対する検知ピークパターンを示している。コカインに対する検知ピークもまた、図18に示されている。図19は、負のイオンモードでの、ラニチジンに対する検知ピークパターンを示している。しかし、図19は、コカインに対する検知ピークを示していない。図20は、負のイオンモードでのコカインに対する検知ピークパターンを示している。
硝酸アンモニウムは、アンモニウムイオンまたは硝酸塩イオンを含む他の分析物と区別することが困難であることがある。IMS分析器は、一方のIM分光計が負のイオンモードでの硝酸塩ピークを検知し、他方のIM分光計が、正のイオンモードでのアンモニウムピークを検知し、硝酸アンモニウムの能動的な検知を許すように構成されてもよい。図21および22は、表2に示すパラメータによって実行されたIonscan(登録商標)500DTイオン移動度分光計(Smith Detection,Inc.)を使用して得られた、検知ピークパターンを示している。図21は、正のイオンモードでのアンモニウムに対する検知ピークパターンを示している。図22は、負のイオンモードでの硝酸塩に対する検知ピークパターンを示している。
この例は、爆発物および麻薬化合物に対する例示的な検知限界を示している。爆発性の化合物は、表2に示されたパラメータを使用して、負のモードでのIonscan(登録商標)500DTイオン移動度分光計(Smith Detection,Inc.)で実行される。
20 ハウジング
30 サンプル挿入領域
40 オペレータインターフェイス
50、52 IM分光計
60 脱着装置
70 CPU
80 空気浄化システム
100 マニュアルサンプリング基板
120 サンプル収集領域
200 サンプリングワンド
210 サンプリングヘッド
220 本体
230 接続機構
240 基板
245 サンプル領域
250 活動化デバイス
253 スイングアーム
255 スイングヘッド
300 サンプル受けデバイス
310 サンプル導入領域
320 ガイド構造
330 ロッキング機構
340 制御ライン
350 ブラケット
355 ピン
360 ロッキング機構ハウジング
A、B、C 矢印
Claims (29)
- サンプルが解析デバイス内への導入のために配置されるサンプル導入領域、およびサンプル受けデバイス内のサンプル収集デバイスを受けるガイド構造を備え、前記サンプル収集デバイスが、前記サンプル収集デバイス上の前記サンプルの前記解析デバイス内への、最適な、またはほぼ最適な導入のために、前記解析デバイス内で適切に配列される、
サンプル受けデバイス。 - 前記解析デバイスが、IMS、IMS/IMS、またはガスクロマトグラフィ/IMSである請求項1に記載のサンプル受けデバイス。
- 前記サンプル収集デバイスが、マニュアルサンプリング基板である請求項1に記載のサンプル受けデバイス。
- 前記サンプル受けデバイスが、前記マニュアルサンプリング基板の挿入が、前記サンプルの解析を開始するように構成されている請求項3に記載のサンプル受けデバイス。
- 前記サンプル収集デバイスが、サンプリングヘッドを備えるサンプリングワンドである請求項1に記載のサンプル受けデバイス。
- 前記サンプリングヘッドを前記サンプル受けデバイス内の定位置にロックするロッキング機構をさらに備える請求項5に記載のサンプル受けデバイス。
- 基板またはサンプリングヘッドに対する脱着サイクルの数を計数するように構成された機構をさらに備える請求項5に記載のサンプル受けデバイス。
- イオン移動度分光計と、
サンプル受けデバイスであって、サンプルが解析デバイス内への導入のために配置されるサンプル導入領域、および前記サンプル受けデバイス内のサンプル収集デバイスを受けるガイド構造を備え、前記サンプル収集デバイスが、前記サンプル収集デバイス上の前記サンプルの前記解析デバイス内への最適な、またはほぼ最適な導入のために前記解析デバイス内で適切に配置されるサンプル受けデバイスと、
脱臭装置と
を備えるイオン移動度分光分析システム、 - 前記サンプル収集デバイスが、マニュアルサンプリング基板である請求項8に記載のイオン移動度分光分析システム。
- 前記サンプル受けデバイスが、前記サンプル収集デバイスの挿入が、前記サンプルの前記サンプル収集デバイスからの脱着を開始するように構成されている請求項8に記載のイオン移動度分光分析システム。
- 前記サンプル収集デバイスが、サンプリングヘッドを備えるサンプリングワンドである請求項8に記載のイオン移動度分光分析システム。
- 前記サンプリングヘッドを前記サンプル受けデバイス内の定位置にロックするロッキング機構をさらに備える請求項11に記載のイオン移動度分光分析システム。
- 基板またはサンプリングヘッドに対する脱着サイクルの数を計数するように構成された機構をさらに備える請求項11に記載のイオン移動度分光分析システム。
- 前記イオン移動度分光計が、第1のイオン移動度分光計であり、第2のイオン移動度分光計をさらに備える請求項8に記載のイオン移動度分光分析システム。
- 前記第1のおよび第2のイオン移動度分光計が、電場極性、電場勾配、ドリフトチューブ温度、取入口温度、反応物質温度、較正温度、ドリフトガス流、サンプルガス流、反応物質流、および較正流から成るグループから選択されるパラメータに関して独立して制御されるように構成されている請求項14に記載のイオン移動度分光分析システム。
- 前記第1のイオン移動度分光計が、最大約300℃またはそれ以上の温度で正のイオンモードで動作し、かつ前記第2のイオン移動度分光計が、約50℃から約100℃の温度で正のイオンモードで動作する請求項15に記載のイオン移動度分光分析システム。
- 前記第1のイオン移動度分光計が、約100℃から約110℃の温度で負のイオンモードで動作し、かつ前記第2のイオン移動度分光計が、約50℃から約70℃の温度で負のイオンモードで動作する請求項15に記載のイオン移動度分光分析システム。
- 前記第1のイオン移動度分光計が、第1の化学のイオン化試薬を使用して正のイオンモードで動作し、かつ前記第2のイオン移動度分光計が、第2の化学のイオン化試薬を使用して負のイオンモードで動作する請求項14に記載のイオン移動度分光分析システム。
- 前記第1の化学物質イオン化試薬が、ニコチンアミドまたはイソブチルアミドであり、かつ前記第2の化学物質イオン化試薬が、塩化物化学物質イオン化試薬である請求項18に記載の前記イオン移動度分光分析システム。
- 前記第1のイオン移動度分光計が、前記第1のイオン化剤と陽子交換を行うであろう分析物の検知を許すために、第1のイオン化試薬を使用して正のイオンモードで動作し、かつ前記第2のイオン移動度分光計が、第2のイオン化剤との電子交換、陽子交換、またはクラスタ化反応を介してイオン化するであろう第2のイオン化試薬によって正のイオンモードで動作する請求項14に記載のイオン移動度分光分析システム。
- 前記第1の化学のイオン化試薬が、ニコチンアミドである請求項20に記載のイオン移動度分光分析システム。
- 前記第1のイオン移動度分光計が、非酸素イオン化試薬によって負のイオンモードで動作し、かつ前記第2のイオン移動度分光計が、酸素試薬によって負のイオンモードで動作する請求項14に記載のイオン移動度分光分析システム。
- 前記非酸素イオン化試薬が、塩化物化学物質のイオン化試薬である請求項22に記載のイオン移動度分光分析システム。
- 前記脱着装置が、加熱された台である請求項8に記載のイオン移動度分光分析システム。
- 前記第1のおよび第2のイオン移動度分光計が、前記脱着装置流体的に接続しており、かつ前記システムが、前記第1のおよび第2のイオン移動度分光計のそれぞれへ移送される前記サンプルの比率を制御するように構成されている、請求項24に記載のイオン移動度分光分析システム。
- 前記イオン移動度分光分析システムが、前記サンプル収集デバイスが前記サンプル受けデバイス内へ挿入されたとき、サンプルの脱着および解析を自動的に開始するように構成されている請求項8に記載のイオン移動度分光分析システム。
- 63Ni、241アメリシウム、またはコロナ排出イオン化源をさらに備える請求項8に記載のイオン移動度分光分析システム。
- 63Niおよびコロナ排出イオン化源をさらに備える請求項8に記載のイオン移動度分光分析システム。
- ドリフトチューブ、試薬導入デバイス、イオン化領域、イオン化源、および検知器を備える第1のイオン移動度分光計と、
ドリフトチューブ、試薬導入デバイス、イオン化領域、イオン化源、および検知器を備える第2のイオン移動度分光計と、
少なくとも1つのイオン化源と、
サンプル収集デバイスを受けるためのサンプル受けデバイスであって、サンプルが導入および解析のために配置されるサンプル導入領域、および前記サンプル受けデバイス内の前記サンプル収集デバイスを受けて配列するガイド構造を備え、前記サンプル収集デバイスが、前記サンプルの前記サンプル収集デバイス上への最適な、またはほぼ最適な導入のために、前記システム内で適切に配列されるサンプル受けデバイスと
を備えるイオン移動度分光分析システム。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/303,012 US20080101995A1 (en) | 2005-12-16 | 2005-12-16 | Ion mobility spectrometer having improved sample receiving device |
PCT/IB2006/004307 WO2008035138A2 (en) | 2005-12-16 | 2006-12-15 | Ion mobility spectrometry analyzer with improved sample receiving device |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009519462A true JP2009519462A (ja) | 2009-05-14 |
Family
ID=39200880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008545147A Pending JP2009519462A (ja) | 2005-12-16 | 2006-12-15 | 改良型のサンプル受けデバイスを備えるイオン移動度分光分析器 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080101995A1 (ja) |
EP (1) | EP1960794A4 (ja) |
JP (1) | JP2009519462A (ja) |
CN (1) | CN101427140A (ja) |
AU (1) | AU2006348555A1 (ja) |
CA (1) | CA2633557A1 (ja) |
RU (1) | RU2008129138A (ja) |
WO (1) | WO2008035138A2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009519461A (ja) * | 2005-12-16 | 2009-05-14 | スミスズ ディテクション‐トロント リミテッド | サンプリング装置 |
JP2016536570A (ja) * | 2013-09-19 | 2016-11-24 | スミスズ ディテクション−ワトフォード リミテッド | 誘導結合ヒータを備えるサンプル採取ワンド |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10073056B2 (en) * | 2006-02-14 | 2018-09-11 | Excellims Corporation | Practical ion mobility spectrometer apparatus and methods for chemical and/or biological detection |
US9523657B2 (en) * | 2006-02-14 | 2016-12-20 | Excellims Corporation | Practical ion mobility spectrometer apparatus and methods for chemical and/or biological detection |
US10309929B2 (en) * | 2006-02-14 | 2019-06-04 | Excellims Corporation | Practical ion mobility spectrometer apparatus and methods for chemical and/or biological detection |
US10794862B2 (en) * | 2006-11-28 | 2020-10-06 | Excellims Corp. | Practical ion mobility spectrometer apparatus and methods for chemical and/or biological detection |
CN101526496B (zh) * | 2008-03-05 | 2013-06-19 | 同方威视技术股份有限公司 | 一种制备离子迁移谱仪校准制样工具的方法 |
CN101587029B (zh) * | 2008-05-21 | 2013-10-23 | 同方威视技术股份有限公司 | 用于痕量探测仪的样品处理系统及方法 |
US9983099B2 (en) * | 2008-06-13 | 2018-05-29 | Smiths Detection Montreal Inc. | Analytical instrument with temporal control of ion mobility spectrometer control parameters |
CN102297791A (zh) * | 2010-06-23 | 2011-12-28 | 中国科学院大连化学物理研究所 | 一种离子迁移谱专用采样薄片的处理方法 |
CN102455318A (zh) * | 2010-10-29 | 2012-05-16 | 中国科学院大连化学物理研究所 | 一种用于检测气溶胶样品的连续监测仪 |
US9297785B2 (en) | 2011-06-24 | 2016-03-29 | Sociedad Europea de Analisis Diferencial de Movilidad | Method for detecting atmospheric vapors at parts per quadrillion (PPQ) concentrations |
US9891193B2 (en) * | 2012-07-24 | 2018-02-13 | Massachusetts Institute Of Technology | Reagent impregnated swipe for chemical detection |
US9588095B2 (en) | 2012-07-24 | 2017-03-07 | Massachusetts Institute Of Technology | Reagents for oxidizer-based chemical detection |
EP2882532A1 (en) * | 2012-08-08 | 2015-06-17 | Smiths Detection-Watford Limited | Inlet closure mechanism |
CN102866044B (zh) * | 2012-09-12 | 2015-04-29 | 奥瑞金包装股份有限公司 | 板状材料离子迁移检测前处理装置及方法 |
US9953820B2 (en) * | 2012-09-21 | 2018-04-24 | Smiths Detection-Watford Limited | Sample collection thermal desorber |
US10816530B2 (en) | 2013-07-23 | 2020-10-27 | Massachusetts Institute Of Technology | Substrate containing latent vaporization reagents |
WO2015154087A1 (en) | 2014-04-04 | 2015-10-08 | Massachusetts Institute Of Technology | Reagents for enhanced detection of low volatility analytes |
US10281366B2 (en) * | 2016-12-09 | 2019-05-07 | Rapiscan Systems, Inc. | Sampling device including mechanical force feedback mechanism |
CN107238653B (zh) * | 2017-05-25 | 2019-07-12 | 中国科学院合肥物质科学研究院 | 超声雾化提取水中非挥发性有机物的质谱检测装置及方法 |
GB2575420B (en) * | 2018-04-30 | 2020-07-22 | Smiths Detection Watford Ltd | Use of a Direction Signal in Controlling a Device for Detecting a Desorbed Sample |
CN109187714B (zh) * | 2018-10-22 | 2021-04-23 | 公安部第三研究所 | 同时适用于阴、阳离子探测模式的校准物、相应方法及应用 |
CN109725047A (zh) * | 2019-02-21 | 2019-05-07 | 北京沃斯彤科技有限公司 | 一种多迁移率大气离子检测装置 |
CA3177454A1 (en) | 2020-05-19 | 2021-11-25 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
CN113804747B (zh) * | 2020-05-29 | 2023-08-01 | 同方威视技术股份有限公司 | 热解吸采样装置、热解吸设备和离子迁移谱仪检测设备 |
CN116626193A (zh) * | 2023-05-23 | 2023-08-22 | 浙江省轻工业品质量检验研究院 | 一种基于gc-ims的皮革与人造革的鉴别方法及应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571976A (en) * | 1994-12-08 | 1996-11-05 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Revenue | Apparatus and method for collecting samples for IMS (Ion Mobility Spectrometers) analyzers and the like |
US5741984A (en) * | 1996-10-21 | 1998-04-21 | Barringer Technologies Inc. | Method and apparatus for sample collection by a token |
CA2190070A1 (en) * | 1996-11-12 | 1998-05-12 | Ludmila Danylewych-May | Apparatus for and method of scanning objects for the presence of trace chemicals |
US5859375A (en) * | 1996-04-03 | 1999-01-12 | Barringer Research Limited | Apparatus for and method of collecting trace samples for analysis |
JP2000504111A (ja) * | 1996-02-02 | 2000-04-04 | グラスビー ダイナミクス リミテッド | 分析測定器のためのコロナ放電イオン源 |
JP2000171427A (ja) * | 1998-09-29 | 2000-06-23 | Omron Corp | 試料成分分析システム並びにこのシステムに使用されるセンサチップ及びセンサパック |
JP2004212073A (ja) * | 2002-12-27 | 2004-07-29 | Hitachi Ltd | 危険物探知装置及び危険物探知方法 |
WO2005001464A1 (en) * | 2003-06-25 | 2005-01-06 | Smiths Group Plc | Ion mobility system comprising two ims cells operated at different polarities |
US20050173629A1 (en) * | 2001-06-30 | 2005-08-11 | Miller Raanan A. | Methods and apparatus for enhanced sample identification based on combined analytical techniques |
WO2005108968A1 (ja) * | 2004-05-12 | 2005-11-17 | Matsushita Electric Industrial Co., Ltd. | バイオセンサ、バイオセンサ用容器、およびバイオセンサ測定装置 |
WO2005116632A2 (en) * | 2004-05-05 | 2005-12-08 | Omniquant Medical, Inc. | Analytical systems, devices, and cartridges therefor |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2002A (en) * | 1841-03-12 | Tor and planter for plowing | ||
FR2648227B1 (fr) * | 1989-06-09 | 1994-01-21 | Etat Francais Delegue Armement | Appareillage portatif et autonome pour l'analyse in situ d'une substance liquide ou solide se presentant sous la forme de depots superficiels |
US5071771A (en) * | 1989-12-04 | 1991-12-10 | Forintek Canada Corporation | Identification of wood species |
US6021681A (en) * | 1997-06-27 | 2000-02-08 | The United States Of America As Represented By The United States Department Of Energy | Sampling device with a capped body and detachable handle |
CN1296564A (zh) * | 1998-02-11 | 2001-05-23 | 劳伦斯·V·哈里 | 使用gc/ims的手持检测系统 |
US6446514B1 (en) * | 2000-01-18 | 2002-09-10 | Barringer Research Limited | Combined particle/vapor sampler |
US7060223B2 (en) * | 2000-03-31 | 2006-06-13 | Neogen Corporation | Polymeric medium for the retention of reagent species for use in a hand-held device for the relatively rapid detection of the presence of an analyte of interest in a sample |
US6627878B1 (en) * | 2000-07-11 | 2003-09-30 | The United States Of America As Represented By The Secretary Of The Navy | (Chemical agent) point detection system (IPDS) employing dual ion mobility spectrometers |
US6765198B2 (en) * | 2001-03-20 | 2004-07-20 | General Electric Company | Enhancements to ion mobility spectrometers |
EP1530416A4 (en) * | 2002-07-30 | 2005-10-19 | Id Pty Ltd Ag | SAMPLING DEVICE |
WO2004082830A2 (en) * | 2003-03-13 | 2004-09-30 | Ascend Instruments, Llc | Sample manipulation system |
US7456393B2 (en) * | 2003-04-10 | 2008-11-25 | Ge Homeland Protection, Inc. | Device for testing surfaces of articles for traces of explosives and/or drugs |
WO2005036130A2 (en) * | 2003-10-08 | 2005-04-21 | Smiths Detection Inc. | Method and system for introducing an analyte into an ion mobility spectrometer |
-
2005
- 2005-12-16 US US11/303,012 patent/US20080101995A1/en not_active Abandoned
-
2006
- 2006-12-15 EP EP06851561.8A patent/EP1960794A4/en not_active Withdrawn
- 2006-12-15 CN CN200680052536.1A patent/CN101427140A/zh active Pending
- 2006-12-15 WO PCT/IB2006/004307 patent/WO2008035138A2/en active Application Filing
- 2006-12-15 AU AU2006348555A patent/AU2006348555A1/en not_active Abandoned
- 2006-12-15 JP JP2008545147A patent/JP2009519462A/ja active Pending
- 2006-12-15 RU RU2008129138/28A patent/RU2008129138A/ru not_active Application Discontinuation
- 2006-12-15 CA CA002633557A patent/CA2633557A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571976A (en) * | 1994-12-08 | 1996-11-05 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Revenue | Apparatus and method for collecting samples for IMS (Ion Mobility Spectrometers) analyzers and the like |
JP2000504111A (ja) * | 1996-02-02 | 2000-04-04 | グラスビー ダイナミクス リミテッド | 分析測定器のためのコロナ放電イオン源 |
US5859375A (en) * | 1996-04-03 | 1999-01-12 | Barringer Research Limited | Apparatus for and method of collecting trace samples for analysis |
US5741984A (en) * | 1996-10-21 | 1998-04-21 | Barringer Technologies Inc. | Method and apparatus for sample collection by a token |
CA2190070A1 (en) * | 1996-11-12 | 1998-05-12 | Ludmila Danylewych-May | Apparatus for and method of scanning objects for the presence of trace chemicals |
JP2000171427A (ja) * | 1998-09-29 | 2000-06-23 | Omron Corp | 試料成分分析システム並びにこのシステムに使用されるセンサチップ及びセンサパック |
US20050173629A1 (en) * | 2001-06-30 | 2005-08-11 | Miller Raanan A. | Methods and apparatus for enhanced sample identification based on combined analytical techniques |
JP2004212073A (ja) * | 2002-12-27 | 2004-07-29 | Hitachi Ltd | 危険物探知装置及び危険物探知方法 |
WO2005001464A1 (en) * | 2003-06-25 | 2005-01-06 | Smiths Group Plc | Ion mobility system comprising two ims cells operated at different polarities |
WO2005116632A2 (en) * | 2004-05-05 | 2005-12-08 | Omniquant Medical, Inc. | Analytical systems, devices, and cartridges therefor |
WO2005108968A1 (ja) * | 2004-05-12 | 2005-11-17 | Matsushita Electric Industrial Co., Ltd. | バイオセンサ、バイオセンサ用容器、およびバイオセンサ測定装置 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009519461A (ja) * | 2005-12-16 | 2009-05-14 | スミスズ ディテクション‐トロント リミテッド | サンプリング装置 |
JP2016536570A (ja) * | 2013-09-19 | 2016-11-24 | スミスズ ディテクション−ワトフォード リミテッド | 誘導結合ヒータを備えるサンプル採取ワンド |
Also Published As
Publication number | Publication date |
---|---|
EP1960794A4 (en) | 2013-05-15 |
WO2008035138A3 (en) | 2008-07-24 |
CA2633557A1 (en) | 2008-03-27 |
EP1960794A2 (en) | 2008-08-27 |
CN101427140A (zh) | 2009-05-06 |
US20080101995A1 (en) | 2008-05-01 |
AU2006348555A1 (en) | 2008-03-27 |
RU2008129138A (ru) | 2010-01-27 |
WO2008035138A2 (en) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009519462A (ja) | 改良型のサンプル受けデバイスを備えるイオン移動度分光分析器 | |
EP1877382B1 (en) | Method of using isobutyramide as an ionization reagent in IMS-spectrometry | |
US9200992B2 (en) | Sampling swab | |
Rearden et al. | Rapid screening of precursor and degradation products of chemical warfare agents in soil by solid-phase microextraction ion mobility spectrometry (SPME–IMS) | |
US7800056B2 (en) | Document sampler and method of sampling a document | |
Sisco et al. | Rapid analysis of trace drugs and metabolites using a thermal desorption DART-MS configuration | |
O’Donnell et al. | Pharmaceutical applications of ion mobility spectrometry | |
Hill et al. | Capabilities and limitations of ion mobility spectrometry for field screening applications | |
EP2510346B1 (en) | Method and apparatus for inspecting a gas sample | |
US9588091B2 (en) | Method and composition for detecting oxidizing salts | |
CA2597094C (en) | Article scanner | |
WO2011060607A1 (zh) | 离子迁移谱仪以及提高其检测灵敏度的方法 | |
Metwally et al. | Detection of opioids on mail/packages using open port interface mass spectrometry (OPI-MS) | |
JP2004125576A (ja) | 危険物探知装置及び危険物探知方法 | |
Pevzner et al. | Sonic-spray introduction of liquid samples to hand-held Ion mobility spectrometry analyzers | |
RU51219U1 (ru) | Устройство для контроля следов взрывчатых веществ на документах | |
US11519826B2 (en) | Alignment tool for dry-deposition and kit for assembling apparatus for verifying explosive trace detector responses | |
US10481135B1 (en) | Separation devices and sensors including two dimensional materials that change properties when exposed to components separated from a sample | |
RU2293303C1 (ru) | Устройство для контроля следов взрывчатых веществ на документах | |
RU2234082C2 (ru) | Способ совместного определения токсичности анилина и нитробензола в воздухе | |
He et al. | FAST DETECTION OF EXPLOSIVES VAPOURS AND PARTICLES BY CHEMILUMINESCENCE | |
Mariella | Sensor systems for the Altair Lunar Lander |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090204 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091208 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120110 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120406 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120413 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120709 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120911 |